Floatz logo

Spironolactone

Alcoholic Cirrhosis

University Hospital, AngersSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Alcoholic Cirrhosis cohort.

Asset / SponsorPhaseRating
PROPRANOLOL
University Hospital, Angers
Phase 4BB
Cellgram-Lc
Pharmicell Co., Ltd.
Phase 3B
S-Adenosyl-L-Methionine
Indiana University
Phase 2CCC
Baclofen
Corporacion Parc Tauli
Phase 1/2CCC
Ciprofloxacin
University of Helsinki
Early Phase 1CC
BLOOD, WHOLE
Assistance Publique - Hôpitaux de Paris
N/AD

Same molecule, other indications

Spironolactone is also rated in:

AscitesDormant
BB
Indicative ·
68 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
diabetic kidney diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →